Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia

@article{MBChB2003ThermalEO,
  title={Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia},
  author={MRCS Faheez Mohamed MBChB and Pierre Marchettini and BS O.AnthonyStuart and Muneyasu Urano and FACS FRCS Paul H. Sugarbaker},
  journal={Annals of Surgical Oncology},
  year={2003},
  volume={10},
  pages={463-468}
}
Background: Hyperthermia enhances the cytotoxicity of some chemotherapeutic agents. We have studied the effect of moderate hyperthermia (41.5°C) on the cytotoxicity of five new chemotherapeutic agents (docetaxel, paclitaxel, irinotecan, oxaliplatin, and gemcitabine) and melphalan against a spontaneous murine fibrosarcoma. Methods: The tumor was an early-generation isotransplant of a spontaneous C3Hf/Sed mouse fibrosarcoma, FSa-II. Hyperthermia was administered by immersing the tumor-bearing… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 51 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 40 references

Effectiveness of 2',2'difluorodeoxycytidine (gemcitabine) combined with hyperthermia in rat R-1 rhabdomyosarcoma in vitro and in vivo

  • C Van Bree, C Beumer, HM Rodermond, J Haveman, PJM. Bakker
  • Int J Hyperthermia
  • 1999

Similar Papers

Loading similar papers…